November 9, 2020 – We are proud to announce the grant recipients of TSF’s 2020 research grants. Congratulations to our recipients who received $25,000 to initiate their projects!
Diagnostics in NMOSD
Farrah Mateen, MD, PhD | Massachusetts General Hospital (Boston, MA)
Aim: To pilot a novel point-of-care dry blood spot diagnostic test for patients with aquaporin 4-antibody (AQP4) seropositive neuromyelitis optica spectrum disorder (NMOSD)
Michael Levy, MD, PhD | Massachusetts General Hospital (Boston, MA)
Aim: To repurpose existing medications to stop the inflammatory process in patients with MOG antibody disease
Autoantibodies in NMOSD
Stacey Clardy, MD, PhD & Jonathan Galli, MD | University of Utah (Salt Lake City, UT)
Describe the epidemiologic characteristics of all patients who carry a diagnosis of NMOSD within the Department of Defense/Defense Medical Surveillance System (DMSS).
Confirm the presence of Aquaporin-4 and MOG autoantibodies in pre-symptomatic NMO samples
Investigating a Relapse Biomarker in MOG-AD
Tanuja Chitnis, MD | Brigham and Women’s Hospital (Boston, MA)
To evaluate dynamics of TNFAIP3 as a relapse biomarker in adults and children with MOG-AD
To evaluate the effects endogenous and exogenous steroids on levels of TNFAIP3 in patients with MOG-AD